CRINETICS PHARMACEUTIC

56,09

25-ноября-24 16:45:01

15 мин. задержка

Акции

+0,03

+0,05%

Сегодняшний диапазон

55,93 - 57,42

ISIN

N/A

Источник

NASDAQ

Crinetics Pharmaceuticals to Host Webcast and Conference Call to Discuss 2021 Clinical Plans and Fourth Quarter and Full Year 2020 Financial Results

24 мар 2021 07:10:00 Источник Nasdaq GlobeNewswire
Crinetics Pharmaceuticals Pipeline Progress on Display at ENDO 2021

22 мар 2021 07:10:00 Источник Nasdaq GlobeNewswire
Crinetics Pharmaceuticals Showcasing Breadth of Pipeline at ENDO 2021 with Presentations on Three Clinical Programs

12 мар 2021 07:10:00 Источник Nasdaq GlobeNewswire
Crinetics Pharmaceuticals Lead ACTH Antagonist for Congenital Adrenal Hyperplasia and Cushing’s Disease (CRN04894) Advances into Phase 1 Study

04 фев 2021 07:10:00 Источник Nasdaq GlobeNewswire
Crinetics Pharmaceuticals Advances CRN04777 for Congenital Hyperinsulinism into Phase 1 Study

03 фев 2021 07:10:00 Источник Nasdaq GlobeNewswire
Crinetics Pharmaceuticals to Review 2020 Accomplishments and Provide 2021 Plans at 39th Annual J.P. Morgan Healthcare Conference

06 янв 2021 07:05:00 Источник Nasdaq GlobeNewswire

<<
<
3
4
5
6
7
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.